PMA P230016
- Device
- MAGE-A4 IHC 1F9 pharmDx
- Applicant
- Agilent Technologies, Inc.
- Product code
- SBL
- Decision date
- 2025-06-27
- Generic name
- Immunohistochemistry Assay, Antibody, Melanoma-associated antigen A4
- Approval order statement
- approval for incorporating a fill-volume tolerance range and software into a vial-filling process
Current openFDA PMA Record#
- Device
- MAGE-A4 IHC 1F9 pharmDx
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P230016
- Supplement
- S002
- Product code
- SBL
- Generic name
- Immunohistochemistry Assay, Antibody, Melanoma-associated antigen A4
- Decision date
- 2025-06-27
- Decision code
- OK30
- Date received
- 2025-04-16
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- approval for incorporating a fill-volume tolerance range and software into a vial-filling process